09.15.14
Monrovia, Calif.-based STAAR Surgical Company, which makes implantable lenses and delivery systems for the eye, has added Louis E. Silverman to its board of directors.
Silverman is currently the chairman and CEO of privately held Advanced ICU Care Inc. a rapidly growing technology enabled health care services company providing tele-ICU (intensive care unit) monitoring services to hospitals nationwide. Previously, he was CEO of Marina Medical Inc. where he achieved a successful exit for the privately held company, and president and CEO of Qualcomm-backed health care start-up LifeComm. Silverman has also served as chief operating officer of Corvel Corporation, a publicly traded national managed care services/technology company that generated seven consecutive years of revenue and earnings growth during his tenure, and he has advised private equity investors on healthcare technology and services portfolio investments as well as boards of directors on growth and general corporate strategy initiatives.
For eight years, Silverman also served as the president and CEO of Quality Systems Inc., a publicly traded developer of medical and dental practice management and patient records software. During his tenure, the company’s revenue increased from an annualized run rate of approximately $35 million to an annualized revenue run rate of $250 million and an increase in the company’s market capitalization from approximately $45 million to approximately $1.2 billion. The company was named to the Forbes 200 list of Best Small Companies during each year of his tenure.
“Lou Silverman has a tremendous track record in developing strategies that generate shareholder value,” said Chairman of the Board Mark Logan. “In addition to his proven leadership as the CEO of several growth companies in the healthcare industry, Lou has been an active participant on the board of directors of several high growth companies including Questcor Pharmaceuticals, which was recently acquired by Mallinkrodt plc for $5.8 billion. We believe Lou’s executive leadership experience with high growth healthcare companies will provide valuable perspective to our Board and we look forward to his contributions.”
“STAAR Surgical is at an inflection point in the company’s development as it continues to gain refractive procedure market share,” said Silverman. “I look forward to working with the board of directors and the management to capitalize on the company’s growth opportunities while continuing to build returns for shareholders.”
Silverman is currently the chairman and CEO of privately held Advanced ICU Care Inc. a rapidly growing technology enabled health care services company providing tele-ICU (intensive care unit) monitoring services to hospitals nationwide. Previously, he was CEO of Marina Medical Inc. where he achieved a successful exit for the privately held company, and president and CEO of Qualcomm-backed health care start-up LifeComm. Silverman has also served as chief operating officer of Corvel Corporation, a publicly traded national managed care services/technology company that generated seven consecutive years of revenue and earnings growth during his tenure, and he has advised private equity investors on healthcare technology and services portfolio investments as well as boards of directors on growth and general corporate strategy initiatives.
For eight years, Silverman also served as the president and CEO of Quality Systems Inc., a publicly traded developer of medical and dental practice management and patient records software. During his tenure, the company’s revenue increased from an annualized run rate of approximately $35 million to an annualized revenue run rate of $250 million and an increase in the company’s market capitalization from approximately $45 million to approximately $1.2 billion. The company was named to the Forbes 200 list of Best Small Companies during each year of his tenure.
“Lou Silverman has a tremendous track record in developing strategies that generate shareholder value,” said Chairman of the Board Mark Logan. “In addition to his proven leadership as the CEO of several growth companies in the healthcare industry, Lou has been an active participant on the board of directors of several high growth companies including Questcor Pharmaceuticals, which was recently acquired by Mallinkrodt plc for $5.8 billion. We believe Lou’s executive leadership experience with high growth healthcare companies will provide valuable perspective to our Board and we look forward to his contributions.”
“STAAR Surgical is at an inflection point in the company’s development as it continues to gain refractive procedure market share,” said Silverman. “I look forward to working with the board of directors and the management to capitalize on the company’s growth opportunities while continuing to build returns for shareholders.”